These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38328865)

  • 1. Association Between Myocardial Oxygenation and Fibrosis in Duchenne Muscular Dystrophy: Analysis by Rest Oxygenation-Sensitive Magnetic Resonance Imaging.
    Zhou Z; Xu R; Cai X; Fu H; Xu K; Yuan W; Song Y; Shi K; Fu C; Li X; Wang C; Guo Y; Yu L; Xu H
    J Magn Reson Imaging; 2024 Feb; ():. PubMed ID: 38328865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T
    Maforo NG; Magrath P; Moulin K; Shao J; Kim GH; Prosper A; Renella P; Wu HH; Halnon N; Ennis DB
    J Cardiovasc Magn Reson; 2020 Dec; 22(1):85. PubMed ID: 33302967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Right Ventricular Function and T1-Mapping in Boys With Duchenne Muscular Dystrophy.
    Dual SA; Maforo NG; McElhinney DB; Prosper A; Wu HH; Maskatia S; Renella P; Halnon N; Ennis DB
    J Magn Reson Imaging; 2021 Nov; 54(5):1503-1513. PubMed ID: 34037289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Native T1 values identify myocardial changes and stratify disease severity in patients with Duchenne muscular dystrophy.
    Olivieri LJ; Kellman P; McCarter RJ; Cross RR; Hansen MS; Spurney CF
    J Cardiovasc Magn Reson; 2016 Oct; 18(1):72. PubMed ID: 27788681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial Strain Using Cardiac MR Feature Tracking and Speckle Tracking Echocardiography in Duchenne Muscular Dystrophy Patients.
    Siegel B; Olivieri L; Gordish-Dressman H; Spurney CF
    Pediatr Cardiol; 2018 Mar; 39(3):478-483. PubMed ID: 29188318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in native T1 values in patients with Duchenne muscular dystrophy with and without late gadolinium enhancement.
    Lang SM; Alsaied T; Khoury PR; Ryan TD; Taylor MD
    Int J Cardiovasc Imaging; 2021 Feb; 37(2):635-642. PubMed ID: 32951096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Troponin I Levels Correlate with Cardiac MR LGE and Native T1 Values in Duchenne Muscular Dystrophy Cardiomyopathy and Identify Early Disease Progression.
    Voleti S; Olivieri L; Hamann K; Gordish-Dressman H; Spurney C
    Pediatr Cardiol; 2020 Aug; 41(6):1173-1179. PubMed ID: 32476037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global, segmental and layer specific analysis of myocardial involvement in Duchenne muscular dystrophy by cardiovascular magnetic resonance native T1 mapping.
    Xu K; Xu HY; Xu R; Xie LJ; Yang ZG; Yu L; Zhou B; Fu H; Liu H; Cai XT; Guo YK
    J Cardiovasc Magn Reson; 2021 Oct; 23(1):110. PubMed ID: 34645467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophy.
    Soslow JH; Damon SM; Crum K; Lawson MA; Slaughter JC; Xu M; Arai AE; Sawyer DB; Parra DA; Damon BM; Markham LW
    J Cardiovasc Magn Reson; 2016 Jan; 18():5. PubMed ID: 26795569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy.
    Raucci FJ; Xu M; George-Durrett K; Crum K; Slaughter JC; Parra DA; Markham LW; Soslow JH
    J Cardiovasc Magn Reson; 2021 Apr; 23(1):48. PubMed ID: 33910579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
    Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
    Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel implementation of cardiac magnetic resonance first-pass perfusion imaging for semi-quantitatively evaluating microvascular dysfunction in paediatric patients with Duchenne muscular dystrophy.
    Xie L; Cai X; Guo Y; Yu L; Li X; Fu C; Xu K; Song Y; Xu R; Liu H; Xu H
    Br J Radiol; 2024 Jan; 97(1153):249-257. PubMed ID: 38263818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac profile of the Czech population of Duchenne muscular dystrophy patients: a cardiovascular magnetic resonance study with T1 mapping.
    Panovský R; Pešl M; Holeček T; Máchal J; Feitová V; Mrázová L; Haberlová J; Slabá A; Vít P; Stará V; Kincl V
    Orphanet J Rare Dis; 2019 Jan; 14(1):10. PubMed ID: 30626423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in duchenne muscular dystrophy.
    Tandon A; Villa CR; Hor KN; Jefferies JL; Gao Z; Towbin JA; Wong BL; Mazur W; Fleck RJ; Sticka JJ; Benson DW; Taylor MD
    J Am Heart Assoc; 2015 Mar; 4(4):. PubMed ID: 25814625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right Ventricular Remodeling Assessed by MRI in Duchenne Muscular Dystrophy.
    Brown NK; Berhane H; Gambetta K; Markl M; Rigsby CK; Robinson JD; Husain N
    J Magn Reson Imaging; 2023 Aug; 58(2):486-495. PubMed ID: 36354274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive oxygenation assessment after acute myocardial infarction with breathing maneuvers-induced oxygenation-sensitive magnetic resonance imaging.
    Shi K; Yang MX; Xia CC; Peng WL; Zhang K; Li ZL; Guo YK; Yang ZG
    J Magn Reson Imaging; 2021 Jul; 54(1):284-289. PubMed ID: 33433045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of post-contrast myocardial t1 in duchenne muscular dystrophy using cardiac magnetic resonance imaging.
    Soslow JH; Damon BM; Saville BR; Lu Z; Burnette WB; Lawson MA; Parra DA; Sawyer DB; Markham LW
    Pediatr Cardiol; 2015 Jan; 36(1):49-56. PubMed ID: 25070387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Adiposity on Cardiovascular Function and Myocardial Fibrosis in Patients With Duchenne Muscular Dystrophy.
    Henson SE; Lang SM; Khoury PR; Tian C; Rutter MM; Urbina EM; Ryan TD; Taylor MD; Alsaied T
    J Am Heart Assoc; 2021 Oct; 10(19):e021037. PubMed ID: 34569261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial late gadolinium enhancement is associated with clinical presentation in Duchenne muscular dystrophy carriers.
    Wexberg P; Avanzini M; Mascherbauer J; Pfaffenberger S; Freudenthaler B; Bittner R; Bernert G; Weidinger F
    J Cardiovasc Magn Reson; 2016 Sep; 18(1):61. PubMed ID: 27660108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial fibrosis by late gadolinium enhancement cardiovascular magnetic resonance in myotonic muscular dystrophy type 1: highly prevalent but not associated with surface conduction abnormality.
    Cardona A; Arnold WD; Kissel JT; Raman SV; Zareba KM
    J Cardiovasc Magn Reson; 2019 May; 21(1):26. PubMed ID: 31046780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.